Log In
BCIQ
Print this Print this
 

AGT-160

  Manage Alerts
Collapse Summary General Information
Company ArmaGen Inc.
DescriptionDual-function IgG formed by fusion of a single chain Fv (ScFc) antibody against the Abeta peptide of Alzheimer's disease to a mAb against the human insulin recepto
Molecular Target Beta amyloid
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today